Patents by Inventor Somphet Suphasawud

Somphet Suphasawud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070003622
    Abstract: A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof. The dosage form is capable of providing a diphenhydramine plasma concentration within a therapeutic range for at least about 24 hours per single dose. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Application
    Filed: April 11, 2005
    Publication date: January 4, 2007
    Applicant: Sovereign Pharmaceuticals, Ltd.
    Inventors: Viswanathan Srinivasan, Juan Menendez, Venkatesh Balasubramanian, Somphet Suphasawud, Ralph Brown, David Brown
  • Publication number: 20060134207
    Abstract: A pharmaceutical dosage form which comprises diphenhydramine and/or a pharmaceutically acceptable salt thereof and at least one second drug. The dosage form provides a plasma concentration within the therapeutic range of the at least one second drug over a period which is coextensive with a substantial part of the period over which the dosage form provides a plasma concentration within the therapeutic range of diphenhydramine or salt thereof. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Application
    Filed: December 16, 2004
    Publication date: June 22, 2006
    Applicant: Sovereign Pharmaceuticals, Ltd.
    Inventors: Viswanathan Srinivasan, Juan Menendez, Venkatesh Balasubramanian, Somphet Suphasawud, Ralph Brown, David Brown
  • Publication number: 20060057205
    Abstract: A pharmaceutical dosage form which comprises phenylepherine or a pharmaceutically acceptable salt thereof and a second drug. The dosage form provides a plasma concentration within the therapeutic range of the second drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of phenylepherine. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Application
    Filed: September 14, 2004
    Publication date: March 16, 2006
    Applicant: Sovereign Pharmaceuticals, Ltd.
    Inventors: Viswanathan Srinivasan, Raph Brown, David Brown, Juan Menendez, Venkatesh Balasubramanian, Somphet Suphasawud
  • Publication number: 20060029664
    Abstract: A pharmaceutical dosage form which comprises carbetapentane and/or a pharmaceutically acceptable salt thereof and an additional drug. The dosage form provides a plasma concentration within the therapeutic range of the additional drug over a period which is coextensive with at least about 70% of the period over which the dosage form provides a plasma concentration within the therapeutic range of carbetapentane. This abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Application
    Filed: August 4, 2004
    Publication date: February 9, 2006
    Applicant: Sovereign Pharmaceuticals, Ltd.
    Inventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Juan Menendez, Venkatesh Balasubramanian, Somphet Suphasawud
  • Publication number: 20050266032
    Abstract: A pharmaceutical dosage form comprising a first drug and a second drug, both of which are selected from decongestants, antitussives, expectorants, analgesics and antihistamines. The dosage form provides a plasma concentration within a therapeutic range of the second drug over a period which is coextensive with at least about 70% of a period over which the dosage form provides a plasma concentration within a therapeutic range of the first drug. This Abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
    Type: Application
    Filed: April 27, 2005
    Publication date: December 1, 2005
    Applicant: Sovereign Pharmaceuticals, Ltd.
    Inventors: Viswanathan Srinivasan, Ralph Brown, David Brown, Himanshu Patel, Juan Menendez, Venkatesh Balasubramanian, Somphet Suphasawud